About this trial
This observational study aims to evaluate skin conductance measurement (SCM) for pain assessment in postoperative newborns.
Pain assessment in newborns is challenging due to their inability to communicate, and current methods rely on intermittent observational scales such as the Neonatal Pain, Agitation and Sedation Scale (N-PASS) in combination with physiological parameters.
Skin conductance reflects sympathetic nervous system activity and provides a continuous, objective measure of stress and pain. This study will investigate the correlation between skin conductance measurements and standard clinical pain assessment tools (N-PASS and vital parameters), as well as explore the potential analgesic effect of skin-to-skin care on postoperative pain.
The study is conducted in a neonatal intensive care unit (NICU) setting where all monitoring and treatments are part of routine clinical care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Neonates admitted to the NICU
Undergoing surgical intervention
Receiving postoperative care at the study site
Disqualifiers
Lack of parental consent (if applicable)
Major congenital conditions affecting autonomic nervous system function
Trial population
Neonates receiving postoperative care in a tertiary neonatal intensive care unit.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Skin conductance to N-PASS score correlation
Correlation between skin conductance measurements and N-PASS scores and vital parameters during the postoperative period
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: